Literature DB >> 5774083

Oral hypoglycaemic drugs.

.   

Abstract

Mesh:

Substances:

Year:  1969        PMID: 5774083      PMCID: PMC1982462     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  8 in total

1.  HYPOTHYROIDISM IN DIABETICS TREATED WITH SULPHONYLUREA.

Authors:  R B HUNTON; M V WELLS; E W SKIPPER
Journal:  Lancet       Date:  1965-09-04       Impact factor: 79.321

2.  Oral hypoglycemic therapy and associated hypothyroidism.

Authors:  G L Schless; C T Lee
Journal:  Ann N Y Acad Sci       Date:  1968-03-26       Impact factor: 5.691

Review 3.  Extrapancreatic and intrapancreatic action of antidiabetic sulphonylureas. A review.

Authors:  J Madsen
Journal:  Acta Med Scand Suppl       Date:  1967

4.  Long-term experience with sulfonylureas and placebo.

Authors:  D L Singer; D Hurwitz
Journal:  N Engl J Med       Date:  1967-08-31       Impact factor: 91.245

5.  Biochemical basis of the sulfonylurea-induced antabuse syndrome.

Authors:  H Podgainy; R Bressler
Journal:  Diabetes       Date:  1968-11       Impact factor: 9.461

6.  The effect of antihyperglycaemic biguanides, implanted into the hypothalamus, on the water consumption of rats.

Authors:  F Bergmann; J Gutman; A Zerachia
Journal:  Clin Sci       Date:  1968-12       Impact factor: 6.124

7.  Fibrinolytic effect of biguanides.

Authors:  G R Fearnley; R Chakrabarti; E D Hocking; J Evans
Journal:  Ann N Y Acad Sci       Date:  1968-03-26       Impact factor: 5.691

8.  The effects of phenformin on peripheral glucose utilization and insulin action in obesity and diabetes mellitus.

Authors:  W J Butterfield
Journal:  Ann N Y Acad Sci       Date:  1968-03-26       Impact factor: 5.691

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.